5 Results for "

CDK2-IN-7

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "CDK2-IN-7" in MCE Product Catalog:

Cat. No.: HY-139651
CAS No.: 2498658-13-0
Target:  

CDK

Research Areas:  

Cancer

CDK2-IN-7 is a CDK2 inhibitor for researching cancer (IC50 < 50 nM).
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-10008
CAS No.: 345627-80-7
Purity:  99.54%
Synonyms: BMS-387032
Target:  

CDK Apoptosis

Research Areas:  

Cancer

SNS-032 (BMS-387032) is a potent and selective inhibitor of CDK2, CDK7, and CDK9 with IC50s of 38 nM, 62 nM and 4 nM, respectively. SNS-032 has antitumor effect .
loading...
    loading...
Cat. No.: HY-175842
CAS No.: 3030279-55-8
Target:  

CDK

Research Areas:  

Cancer

CDK2 degrader 7 is an orally active CDK2 degrader, with DC50 values of 13 nM (MKN1cells) and 17 nM (TOV21G cells). CDK2 degrader 7 induces G1 phase arrest in MKN1 cells. CDK2 degrader 7 achieves tumor stasis in HCC1569 (CCNE1-amplified) xenograft models. CDK2 degrader 7 can be used for the study of CCNE1-amplified cancers .
loading...
    loading...
Cat. No.: HY-163856
CAS No.: 3040999-70-7
Research Areas:  

Cancer

CDK7-IN-30 (Compound 22) is a CDK7 inhibitor (IC50 = 7.21 nM) that effectively inhibits the phosphorylation of RNA Polymerase II and CDK2. CDK7-IN-30 CDK7-IN-30 can induce cell apoptosis and has anti-cancer activity and can be used in cancer research .
loading...
    loading...
Cat. No.: HY-10008R
CAS No.: 345627-80-7
Synonyms: BMS-387032 (Standard)
Research Areas:  

Cancer

SNS-032 (Standard) is the analytical standard of SNS-032. This product is intended for research and analytical applications. SNS-032 (BMS-387032) is a potent and selective inhibitor of?CDK2, CDK7, and CDK9 with?IC50s?of 38 nM, 62 nM and 4 nM, respectively. SNS-032 has antitumor effect .
loading...
    loading...